AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2025
Oct 3, 2025
35119_dirs_2025-10-03_74b825d0-a395-4b6d-8959-fa37302f7cfc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2025-10-02
Reporting Person: SCHABER CHRISTOPHER J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-02 | Common Stock | P | 15132 | $1.3217 | Acquired | 15511 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $1.32 to $1.325. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3